The incidence of kidney stone disease in the United States has doubled over 15 years with a prevalence now equivalent to that of diabetes. Despite the high morbidity of kidney stones, most existing medical and surgical treatments for children and adults with kidney stones are not supported by high-quality evidence. In addition, use of patient-reported outcomes in existing trials is lacking.